Autonomix Medical, Inc. Common Stock
Autonomix Medical, Inc. Common Stock (AMIX) Revenue
Annual & quarterly revenue history · segment & region breakdown
AMIX · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsAutonomix Medical, Inc. Common Stock trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from $0.00B in FY2026.
Revenue trend
2026 – 2022 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2026-03-31 | $0.00B | +$0.00B | — |
| 2025-03-31 | $0.00B | +$0.00B | — |
| 2024-03-31 | $0.00B | +$0.00B | — |
| 2023-03-31 | $0.00B | +$0.00B | — |
| 2022-03-31 | $0.00B | — | — |
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Autonomix Medical, Inc. Common Stock receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Autonomix Medical, Inc. Common Stock reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Autonomix Medical, Inc. Common Stock's 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
AMIX revenue · 4 questionsAMIX's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from $0.00B in FY2026.
▸ Source: FMP · Autonomix Medical, Inc. Common Stock SEC filings · GAAP · Autonomix Medical, Inc. Common Stock SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026